Designing mouse behavioral tasks relevant to autistic-like behaviors

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 10, Issue 4, 2004, Pages 248-258

  Crawley, Jacqueline N ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; Autism; Mice; Olfactory communication; Reversal learning; Social approach; Social interaction; Ultrasonic vocalizaitons

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTISM; CHEMICAL MUTAGENESIS; COMPULSION; CONTROLLED STUDY; GENETICS; LEARNING; MAZE TEST; MENTAL STRESS; MOUSE; NONHUMAN; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SOCIAL INTERACTION; TASK PERFORMANCE; VOCALIZATION;

ANIMAL COMMUNICATION; ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; SOCIAL BEHAVIOR;

EID: 13444250843     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.20039     Document Type: Review

References (173)

1. Alarcon M, Cantor RM, Liu J, et al. 2002. Autism genetic research exchange consortium: Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 70:60-71.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.
3. Andres C. 2002. Molecular genetics and animal models in autistic disorders. Brain Res Bull 57:109-119.
4. Bacchelli E, Blasi F, Biondolillo M, et al. 2003. Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 8:916-924.
5. Bakker J. 2003. Sexual differentiation of the neuroendocrine mechanisms regulating mate recognition in mammals. J Neuroendocrinol 15:615-621.
6. Ballaban-Gil and Tuchman. 2000. Epilepsy and epileptiform EEG: Association with autism and language disorders. MRDD Res Rev 6:300-308.
7. Baranek GT. 2002. Efficacy of sensory and motor interventions for children with autism. J Autism Dev Disord 32:397-422.
8. Barrett S, Beck JC, Bernier R, et al. 1999. An autosomal genomic screen for autism: Collaborative linkage study of autism. Am J Med Genet 88:609-615.
9. Berger-Sweeney J. 2003. Using mice to model cognitive deficits in neurologic disorders: Narrowing in on Rett syndrome. Curr Neurol Neurosci Rep 3:185-187.
10. Berger-Sweeney J, Stearns NA, Frick KM, et al. 2000. Cholinergic basal forebrain is critical for social transmission of food preferences. Hippocampus 10:729-738.
11. Bespalova IN, Buxbaum JD. 2003. Disease susceptibility genes for autism. Ann Med 35:274-281.
12. Bielsky IF, Hu SB, Szegda KL, et al. 2004. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin Via receptor knockout mice. Neuropsychopharmacology 29:483-493.
13. Biola O, Angel JM, Avner P, et al. 2003. The nature and identification of quantitative trait loci: A community's view. Nat Rev Genet 4:911-916.
14. Blanchard DC, Griebel G, Blanchard RJ. 2003. The mouse defense test battery: Pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol 28:97-116.
15. Bodfish JW, Symons FJ, Parker DE, et al. 2000. Varities of repetitive behavior in autism: Comparisons to mental retardation. J Autism Dev Disord 30:237-243.
16. Bradford Y, Haines J, Hutcheson H, et al. 2001. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 105:539-547.
17. Branchi I, Santucci D, Puopolo M, et al. 2004. Neonatal behaviors associated with ultrasonic vocalizations in mice (Mus musculus): A slow motion analysis. Dev Psychobiol 44:37-44.
18. Branchi I, Santucci D, Vitale A, et al. 1998. Ultrasonic vocalizations by infant laboratory mice: A preliminary spectrographic characterization under different conditions. Dev Psychobiol 33:249-256.
19. Brodkin ES, Hagemann A, Nemetski SM, et al. 2004. Social approach-avoidance behavior of inbred mouse strains towards DVA/2 mice. Brain Res 1002:151-157.
20. Brunner D, Buhot MC, Hen R, et al. 1999. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav Neurosci 113:587-601.
21. Caine SB, Negus SS, Mello NK. 1999. Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology 147:22-24. 22-24.
22. Carter CS. 2003. Developmental consequences of oxytocin. Physiol Behav 79:383-397.
23. Carter CS, Williams JR, Witt DM, et al. 1992. Oxytocin and social bonding. Ann N Y Acad Sci 652:204-211.
24. Carter RJ, Lione LA, Humby T, et al. 1999. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248-3257.
25. Carter RJ, Morton AJ, Dunnett SB. 2001. Motor coordination and balance in rodents. Curr Protocols Neurosci 8:12.1-12.14.
26. Chen L, Toth M. 2001. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050.
27. Clement Y, Calatayud F, Belzung C. 2002. Genetic basis of anxiety-like behaviour: A critical review. Brain Res Bull 57:57-71.
28. Comery TA, Harris JB, Willems P, et al. 1997. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401-5404.
29. Contarino A, Heinrichs SC, Gold LH. 1999. Understanding corticotropin releasing factor neurobiology: Contributions from mutant mice. Neuropeptides 33:1-12.
30. Cook EH. 2001. Genetics of autism. Child Adolesc Psychiatr Clin N Am 10:333-350.
31. Courchesne E, Carper R, Akshoomoff N. 2003. Evidence of brain overgrowth in the first year of life in autism. J Am Med Assoc 290:337-344.
32. Covington HE, Miczek KA. 2003. Vocalizations during withdrawal from opiates and cocaine: Possible expressions of affective distress. Eur J Pharmacol 467:1-13.
33. Crabbe JC. 2002. Alcohol and genetics: New models. Am J Med Genet 114:969-974.
34. Crawley JN. 1985. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9:37-44.
35. Crawley JN. 2000. What's Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. Wiley-Liss: New York.
36. Crawley JN. 2003. Behavioral phenotyping of rodents. Comp Med 53:140-146.
37. Crawley JN, Belknap JK, Collins A, et al. 1997. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology 132:107-124.
38. Crawley JN, Mufson EJ, Hohmann JG, et al. 2002. Galanin overexpressing transgenic mice. Neuropeptides 36:145-156.
39. Crawley JN, Paylor R. 1997. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31:197-211.
40. Cryan JF, Markou A, Lucki I. 2002. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci 23:238-245.
41. Cunningham CL, Ferree NK, Howard MA. 2003. Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology 170:409-422.
42. Cure Autism Now. 2004. http://www.canfoundaoon.org.
43. Dawson G, Toth K, Abbott R, et al. 2004. Early social attention impairments in autism: Social orienting, joint attention, and attention to distress. Dev Psychol 40:271-283.
44. Dawson G, Webb S, Schellenberg GD, et al. 2002. Defining the broader phenotype of autism: Genetic, brain, and behavioral perspectives. Dev Psychopathol 14:581-611.
45. Deuel RK. 2002. Autism: A cognitive developmental riddle. Pediatric Neurol 26:349-357.
46. Dierssen M, Filiat C, Crnic L, et al. 2001. Murine models for Down syndrome. Physiol Behav 73:859-871.
47. Doussard-Roosevelt JA, Joe CM, Bazhenova OV, et al. 2003. Mother-child interaction in autistic and nonautistic children: Characteristics of maternal approach behaviors and child social responses. Dev Psychopathol 15:277-295.
48. Edelson SM, Edelson MG, Kerr DC, et al. 1999. Behavioral and physiological effects of deep pressure on children with autism: A pilot study evaluating the efficacy of Grandin's Hug Machine. Am J Occup Ther 53:145-152.
49. Ferguson JN, Young LJ, Hearn EF, et al. 2000. Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284-288.
50. File SE. 1997. Animal tests of anxiety. Curr Protocols Neurosci 8:1-21.
51. File SE. 2001. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125:151-157.
52. Filipek PA, Accardo PJ, Baranek GT, et al. 1999. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 29:439-484.
53. Finn DA, Rutledge-Gorman MT, Crabbe JC. 2003. Genetic animal models of anxiety. Neurogenetics 4:109-135.
54. Floody OR, Cooper TT, Albers HE. 1998. Injection of oxytocin into the medial preoptic-anterior hypothalamus increases ultrasound production by female hamsters. Peptides 19:833-839.
55. Folstein SE, Rosen-Sheidley B. 2001. Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2:943-955.
56. Frankland PW, Wang Y, Rosner B, et al. 2004. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417-425.
57. Frith U. 1991. Autism and Asperger Syndrome. Cambridge, UK: Cambridge University Press.
58. Galef BG. 1992. Ontogeny and social transmission of food preferences in mammals: Basic and applied research. Appetite 19:309-311.
59. Geyer MA, Swerdlow NR. 1998. Measurement of startle response, prepulse inhibition, and habituation. Curr Protocols Neurosci 8:7.1-7.15.
60. Ghaziuddin M, Butler E. 1998. Clumsiness in autism and Asperger syndrome: A further report. J Intellect Disabil Res 42:43-48.
61. Giardina WJ. 2000. Models of epilepsy: Electroshock and chemical induced convulsions in the mouse. Curr Protocols Pharmacol 5:22.1-22.22.
62. Gillott A, Furniss F, Walter A. 2001. Anxiety in high-functioning children with autism. Autism 5:277-286.
63. Gingrich JA, Hen R. 2001. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155:1-10.
64. Gheusi G, Bluthe RM, Goodall G, et al. 1994. Social and individual recognition in rodents: Methodological aspects and neurobiological bases. Behav Process 33:59-88.
65. Glasson EJ, Bower C, Petterson B, et al. 2004. Perinatal factors and the development of autism. Arch Gen Psychiatry 61:618-627.
66. Gold LH. 1999. Hierarchical strategy for phenotypic analysis in mice. Psychopharmacology 147:2-4.
67. Grant EC, MacIntosh JH. 1963. A comparison of the social postures of some common laboratory rodents. Behaviour 21:246-259.
68. Hahn ME, Schanz N. 2002. The effects of cold, rotation, and genotype on the production of ultrasonic calls in infant mice. Behav Genet 32:267-273.
69. Happé F, Ehlers S, Fletcher P, et al. 1996. 'Theory of mind' in the brain: Evidence from a PET scan study of Asperger syndrome. NeuroReport 8:197-201.
70. Harrington JE. 1976. Recognition of territorial boundaries by olfactory cues in mice (Mus musculus L.). Z Tierpsychol 41:295-306.
71. Harvey MT, Kennedy CH. 2002. Polysomnographic phenotypes in developmental disabilities. Int J Dev Neurosci 20:443-448.
72. Heyser CJ. 2003. Assessment of developmental milestones in rodents. Curr Protocols Neurosci 8.18:1-15.
73. Higgins GA, Jacobsen H. 2003. Transgenic mouse models of Alzheimer's disease: Phenotype and application. Behav Pharmacol 14:419-438.
74. Hill JM, Ades AM, McCune SK, et al. 2003. Vasoactive intestinal peptide in the brain of a mouse model of Down syndrome. Exp Neurol 183:56-65.
75. Hofer MA. 1996. Multiple regulators of ultrasonic vocalization in the infant rat. Psychoneuroendocrinology 21:203-217.
76. Hofer MA, Shair HN, Brunelli SA. 2001. Ultrasonic vocalizations in rat and mouse pups. Curr Protocols Neurosci 8:14.1-14.16.
77. Hollander E, King A, Delaney K, Smith CJ, Silverman JM. 2003. Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Res 117:11-16.
78. Holmes A. 2001. Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci Biobehav Rev 25:261-273.
79. Holmes A, Kinney JW, Wrenn CC, et al. 2003. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus maze. Neuropsychopharmacology 28:1031-1044.
80. 1A receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28:2077-2088.
81. Hsiao Ashe K. 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learning Memory 8:301-308.
82. Ingram JL, Peckham SM, Tisdale B, et al. 2000. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319-324.
83. Insel TR. 2001. Mouse models of autism: Report from a meeting. Mamm Genome 12:755-757.
84. Insel TR, O'Brien DJ, Leckman JF. 1999. Oxytocin, vasopressin, and autism: Is there a connection? Biol Psychiatry 45:145-157.
85. Ivanenko A, Crabtree VM, Gozal D. 2004. Sleep in children with psychiatric disorders. Pediatr Clin North Am 51:51-68.
86. Jamain S, Betancur C, Giros B, et al. 2003a. Genetics of autism: From genome scans to candidate genes. Med Sci (Paris) 11:1081-1090.
87. Jamain S, Quach H, Betancur C, et al. 2003b. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29.
88. Jones BC, Tarantino LM, Rodriguez LA, et al. 1999. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. Pharmacogenetics 9:607-617.
89. Kanner L. 1943. Autistic disturbances of affective contact. Nervous Child 2:217-250.
90. Keller F, Persico AM. 2003. The neurobiological context of autism. Mol Neurobiol 28:1-22.
91. Keverne EB. 2002. Mammalian pheromones: From genes to behaviour. Curr Biol 12:R807-R809.
92. Kinney JW, Starosta G, Holmes A, et al. 2002. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learning Memory 9:178-190.
93. Kitamura Y, Shimohama S, Akaike A, et al. 2000. The parkinsonian models: Invertebrates to mammals. Jpn J Phamacol 84:237-243.
94. Konkle AT, Baker SL, Kentner AC, et al. 2003. Evaluation of the effects of chronic mild Stressors on hedonic and physiological responses: Sex and strain compared. Brain Res 992:227-238.
95. Kooy RF. 2003. Of mice and the Fragile X syndrome. Trends Genet 19:148-154.
96. Kramer KM, Cushing BS, Carter CS. 2003. Developmental effects of oxytocin on stress response: Single versus repeated exposure. Physiol Behav 79:775-782.
97. Landgraf R, Frank E, Aldag JM, et al. 2003. Viral vector-mediated gene transfer of the vole Via vasopressin receptor in the rat septum: Improved social discrimination and active social behaviour. Eur J Neurosci 18:403-411.
98. Laviola J, Terranova ML. 1998. The developmental psychobiology of behavioural plasticity in mice: The role of social experiences in the family unit. Neurosci Biobehav Rev 23:197-213.
99. Lijam N, Paylor R, McDonald MP, et al. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895-905.
100. Liu J, Nyholt DR, Magnussen P, et al. 2001. A genomewide screen for autism susceptibility loci. Am J Hum Genet 69:327-340.
101. Long JM, LaPorte P, Paylor R, et al. 2004. Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav 3:51-62.
102. Lonstein JS, Fleming AS. 2003. Parental behaviors in rats and mice. Curr Protocols Neurosci 8.15:1-26.
103. Lord C, Risi S, Lambrecht L, et al. 2000. The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205-223.
104. Loveland KA, Pearson DA, Tunali-Kotoski B, et al. 2001. Judgments of social appropriateness by children and adolescents with autism. J Autism Dev Disord 31:367-376.
105. Markou A, Koob GF. 1991. Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
106. Martin LA, Goldowitz D, Mittleman G. 2003. The cerebellum and spatial ability: Dissection of motor and cognitive components with a mouse model system. Eur J Neurosci 18:2002-2010.
107. Matthews K, Robbins TW. 2003. Early experience as a determinant of adult behavioural responses to reward: The effects of repeated maternal separation in the rat. Neurosci Biobehav Rev 27:45-55.
108. Maxson SC, Canastar A. 2003. Conceptual and methodological issues in the genetics of mouse agonistic behavior. Horm Behav 44:258-262.
109. Meisler MH, Kearney J, Ottman R, et al. 2001. Identification of epilepsy genes in human and mouse. Annu Rev Genet 35:567-588.
110. Meldrum BS. 1997. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia Suppl 9:S7-S15.
111. Mesibov GB, Shea V, Adams LW. 2001. Understanding Asperger syndrome and high functioning autism. Kluwer Academic/Plenum Publishers: New York.
112. Moran TH, Capone GT, Knipp S, et al. 2002. The effects of piracetam on cognitive performance in a mouse model of Down's syndrome. Physiol Behav 77:403-409.
113. Moreau JL. 1997. Validation of an animal model of anhedonia, a major symptom of depression. Encephale 23:280-289.
114. Morris RG. 2001. Episodic-like memory in animals: Psychological criteria, neural mechanisms and the value of episodic-like tasks to investigate animal models of neurodegenerative disease. Philos Trans R Soc Lond B Biol Sci 356:1453-1465.
115. Moy SS, Nadler JJ, Perez A, et al. 2004. Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behaviors in mice. Genes Brain Behav 3:287-302.
116. Muhle R, Trentacoste SV, Rapin I. 2004. The genetics of autism. Pediatrics 113:472-486.
117. Nadler JJ, Moy SS, Dold G, et al. 2004. Automated apparatus for rapid quantitation of social approach behaviors in mice. Genes Brain Behav 3:303-314.
118. National Alliance for Autism Research. 2004. www.exploringauosm.org and www.naar.org.
119. Nelson RJ, Young KA. 1998. Behavior in mice with targeted disruption of single genes. Neurosci Biobehav Rev 22:453-462.
120. Nestler EJ, Gould E, Manji H, et al. 2002. Preclinical models: Status of basic research in depression. Biol Psychiatry 52:503-528.
121. Nevison CM, Armstrong S, Beynon RJ, et al. 2003. The ownership signature in mouse scent marks is involatile. Proc R Soc Lond Biol Sci 270:1957-1963.
122. Nielsen DM, Derber WJ, McClellan DA, et al. 2002. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 927:8-17.
123. Overstreet DH, Commissaris RC, De La Garza R 2nd, et al. 2003. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: Evidence from genetic models. Stress 6:101-110.
124. Panksepp J, Siviy S, Normansell L. 1984. The psychobiology of play: Theoretical and methodological perspectives. Neurosci Biobehav Rev 8:465-492.
125. Paul R. 2003. Promoting social communication in high functioning individuals with autistic spectrum disorders. Child Adolesc Psychiatr Clin North Am 12:87-106, vi-vii.
126. Pellock JM. 2004. Understanding co-morbidities affecting children with epilepsy. Neurology; 62: S17-S23.
127. Picciotto MR, Wickman K. Using knockout and transgenic mice to study physiology and behavior. Physiol Rev 1998; 78:1131-1163.
128. Pitkow LJ, Sharer CA, Ren X, et al. Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J Neurosci 2001; 21: 7392-7396.
129. Piven J. The broad autism phenotype: A complementary strategy for molecular genetics studies of autism. Am J Med Genet (Neuropsychiatric Genet) 2001; 105: 34-35.
130. Piven J, Nehme E, Simon J, et al. Magnetic resonance imaging in autism: Measurement of the cerebellum, pons, and fourth ventricle. Biol Psychiatry 1992; 31: 491-504.
131. Piven J, Palmer P, Jacobi D, et al. Broader autism phenotype: Evidence from a family history study of multiple-incidence autism families. Am J Psychiatry 1997; 154: 185-190.
132. Pongrac J, Middleton FA, Lewis DA, et al. Gene expression profiling with DNA microarrays: Advancing our understanding of psychiatric disorders. Neurochem Res 2002; 27: 1049-1063.
133. Ripoll N, David DJ, Dailly E, et al. Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 2003; 143: 193-200.
134. Risch N, Spiker D, Lotspeich L, et al. A genomic screen of autism: Evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493-507.
135. Rissman E, Rissman EF, Wersinger SR, et al. Sex with knockout models: Behavioral studies of estrogen receptor alpha. Brain Res 1999 835: 80-90.
136. Rocha BA, Goulding EH, O'Dell LE, et al. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 2002; 22: 10039-10045.
137. Rodgers RJ. Animal models of 'anxiety': Where next? Behav Pharmacol 1997; 8: 477-496.
138. Rodier PM, Ingram JL, Tisdale B, et al. Embryological origin of autism: Developmental anomalies of the cranial motor nuclei. J Comp Neurol 1996;24: 247-261.
139. Salinger WL, Ladrow P, Wheeler C. Behavioral phenotype of the reeler mutant mouse: Effects of RELN gene dosage and social isolation. Behav Neurosci 2003; 117: 1257-1275.
140. Sarter M. Measurement of cognitive abilities in senescent animals. Int J Neurosci 1987; 32: 765-774.
141. Schloper E, Mesibov G, Editors. 1987. Neurobiological issues in autism. Plenum Press, New York.
142. Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 2001; 125: 109-125.
143. Shastry BS. Molecular genetics of autism spectrum disorders. J Hum Genet 2003; 48: 495-501.
144. Shao Y, Wolpert CM, Raiford KL, et al. Genomic screen and follow-up analysis for autism disorders. Am J Med Genet Neuropsychiatr Genet 2002; 114: 99-105.
145. Sinkkonen ST, Homanics GE, Korpi ER. Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations. Neurosci Lett 2003; 340: 205-208.
146. Tabakoff B, Bhave SV, Hoffman PL. Selective breeding, quantitative trait loci analysis, and gene arrays identify candidate genes for complex drug-related behaviors. J Neurosci 2003; 23: 4491-4481.
147. Tafti M, Franken P. Functional genomics of sleep and circadian rhythm invited review: Genetic dissection of sleep. J Appl Physiol 2002; 92: 1339-1347.
148. Taheri S, Mignot E. The genetics of sleep disorders. Lancet 2002; Neurology 1: 242-250.
149. Tecott LH. The genes and brains of mice and men. Am J Psychiatry 2003; 160: 646-656.
150. Tsai LY. Psychopharmacology in autism. Psychosom Med 1999; 61: 651-665.
151. Turner CA, Presti MF, Newman HA, et al. Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet 2001; 31: 393-400.
152. Upton N, Stratton S. Recent developments from genetic mouse models of seizures. Curr Opin Pharmacol 2003; 3: 19-26.
153. Volkmar FR, Pauls D. Autism. Lancet 2003; 362: 1133-1141.
154. Waage-Baudet H, Lauder JM, Dehart DB, et al. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: Implications for autism. Int J Dev Neurosci 2003; 21: 451-459.
155. Wahlsten D, Rustay NR, Metten P, et al. In search of a better mouse test. Trends Neurosci 2003; 26: 132-136.
156. Wassif CA, Zhu P, Kratz L, et al. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum Mole Genet 2001; 10: 555-564.
157. Wassink TH. 2004. The search for autism disease genes. Ment Retard Dev Disabil Res Rev This issue.
158. Wassink TH, Piven J. The molecular genetics of autism. Curr Psychiatry Rep 2000; 2: 170-175.
159. Watase K, Zoghbi HY. Modelling brain diseases in mice: The challenges of design and analysis. Nat Rev Genet 2003; 4: 296-307.
160. Wehner JM, Radcliffe RA, Bower BJ. Quantitative genetics and mouse behavior. Annu Rev Neurosci 2001; 24: 845-867.
161. 1B receptor knockout mice. Dev Psychobiol 2003; 42: 194-205.
162. Winslow JT. Mouse social recognition and preference. Curr Protocols Neurosci 2003; 8.16: 1-12.
163. Winslow JT, Hearn EF, Ferguson J, et al. Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm Behav 2000; 37: 145-155.
164. Winslow JT, Insel TR. The social deficits of the oxytocin knockout mouse. Neuropeptides 2002; 36: 221-229.
165. Wrenn CC, Harris AP, Saavedra MC, et al. Social transmission of food preference in mice: Methodology and application to galanin-overexpressing transgenic mice. Behav Neurosci 2003; 117: 21-31.
166. Wrenn CC, Kinney JW, Marriott LK, et al. Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur J Neurosci 2004; 19: 1384-1396.
167. Yamada M, Basile AS, Fedorova I, et al. Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology. Life Sci 2003; 74: 345-353.
168. Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E, et al. Genome-wide scan for loci of Asperger's syndrome. Mol Psychiatry 2004; 9: 161-168.
169. Yonan AL, Palmer AA, Smith KC, et al. Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction. Genes Brain Behav 2003; 2: 303-320.
170. Young LJ. Oxytocin and vasopressin as candidate genes for psychiatric disorders: Lessons from animal models. Am J Med Genet 2001; 105: 53-54.
171. Young LJ, Pitkow LJ, Ferguson JN. Neuropeptide and social behavior: Animal models relevant to autism. Mol Psychiatry 2002; 7: S38-S39.
172. Zirlinger M, Anderson D. Molecular dissection of the amygdale and its relevance to autism. Genes Brain Behav 2003; 2: 282-294.
173. Zoghbi HY. Postnatal neurodevelopmental disorders: Meeting at the synapse? Science 2003; 302: 826-830.